Our healthcare company clients have ranged from start-ups to Fortune 500 international firms. We firmly believe reimbursement and payer strategy is an integral part of an overall growth strategy. Therefore, our work is often directly with CEO and CFO level management and we have experience preparing management for board meetings or presenting to the board ourselves. Our analysis can be utilized when expanding into new markets or launching new products and can be used to make decisions on new sales staff locations.
Our diligence work is often for private equity firms involving a leveraged buyout but sometimes entails growth capital, venture capital, distressed investments, and mezzanine capital. We also work with lenders on diligence projects and investment banks when bringing a company to market. In this case, we provide a landscape analysis involving reimbursement, compliance, and a claims review.
We do not sell research or contract with firms that invest or trade in public securities (e.g. hedge, mutual, or pension funds).
Here is a sampling of case studies for both our corporate consulting clients and diligence for private equity, lenders, and investment banks: